Sign Up to like & get
recommendations!
1
Published in 2018 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2017.11.043
Abstract: ABSTRACT Renal fibrosis yields decreased renal function and is a potent contributor to chronic kidney disease (CKD). Telbivudine (LdT) is an anti–hepatitis B virus (HBV) drug that has been found to steadily improve renal function,…
read more here.
Keywords:
bgr smad;
fibrosis;
kgr;
renal fibrosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.13436
Abstract: The efficacy of telbivudine for breaking vertical transmission of hepatitis B virus has been well established. Data on the risk of postpartum flare after telbivudine withdrawal and efficacy of extended antiviral therapy after delivery are…
read more here.
Keywords:
flare telbivudine;
efficacy;
telbivudine withdrawal;
withdrawal efficacy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.12834
Abstract: Infection of hepatitis B virus (HBV) occurs in ~10% of infants of HBV‐infected mothers with positive hepatitis B e antigen (HBeAg) after immunoprophylaxis. We aimed to evaluate the safety and efficacy of telbivudine used during…
read more here.
Keywords:
pregnancy;
hepatitis;
transmission;
hbv ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "BMC Gastroenterology"
DOI: 10.1186/s12876-017-0572-2
Abstract: BackgroundTelbivudine has been suggested to induce hepatitis B surface antigen (HBsAg) decline to the similar degree as pegylated interferon. We aimed to investigate whether telbivudine could further decrease HBsAg titer in patients who maintain undetectable…
read more here.
Keywords:
entecavir;
trial;
dna;
hepatitis ... See more keywords